This is a test done before an embryo is placed into the uterus. It checks the genetic makeup of the embryo for any potential problems. This helps doctors decide if an embryo is healthy enough to implant.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Preimplantation diagnosis, now usually called preimplantation genetic testing (PGT), checks embryos created through in vitro fertilization (IVF) for a specific genetic problem before one is placed in the uterus. The aim is to choose an embryo that does not carry a serious condition known to run in the family, rather than discovering the condition during a pregnancy. It is mainly used by people who already know they are at high risk of passing on a genetic condition, often after a child or relative was diagnosed. Testing for a single-gene condition (called PGT-M) suits couples in which one or both partners carry a known disease-causing gene change. Testing for structural rearrangements (PGT-SR) helps when a parent carries a chromosome that is rearranged, such as a translocation, which can leave embryos with missing or extra genetic material. Less often, embryos are tested to find one whose tissue type matches a sick brother or sister who needs a stem cell transplant. A broader test, PGT-A, screens embryos for extra or missing whole chromosomes (aneuploidy). It is widely offered as an add-on to IVF, but large trials have not shown that it improves the overall chance of pregnancy for IVF patients in general, and who benefits from it is still debated. Before choosing PGT, genetic counseling covers the other reproductive options, such as conceiving without IVF and testing during the pregnancy, or using donor eggs or sperm. For people who could otherwise conceive without help, the choice also means taking on the cost and demands of IVF.
Preparation starts well before IVF begins. A genetic counselor or clinical geneticist reviews the family history and the exact genetic finding, explains what the test can and cannot detect, and goes through the alternatives without steering the decision. For PGT-M, the laboratory usually builds a test tailored to the family. This preparatory work-up often needs DNA samples from both partners and from relatives whose genetic status is known, and it has to be finished before a treatment cycle starts, which adds time. The IVF part follows the usual pattern: blood tests and ultrasound scans, then a course of hormone injections to mature several eggs at once. The number of eggs matters more than usual, because some embryos will turn out to be affected or will not develop well enough to be tested. Before starting, the clinic should explain the total cost and timeline, its own error rates and live birth rates for this kind of testing, and what will happen to embryos that are affected or not used.
Eggs are collected in a short procedure, usually in the clinic. With medicine to prevent pain, the doctor passes a thin needle through the vagina into each ovary, guided by ultrasound, and gently draws out the eggs. In the laboratory the eggs are fertilized, sometimes by injecting a single sperm directly into each egg, and the embryos are grown for about five days until they reach the blastocyst stage. At that point an embryologist removes a few cells, usually 5 to 10, from the outer layer of each embryo. This step is called an embryo biopsy and happens entirely in the laboratory. The cells go to a genetics laboratory, and the embryos are usually frozen while the results are prepared. Later, an embryo found to be unaffected is thawed and transferred into the uterus through a thin tube passed through the cervix. The transfer is brief and is done while awake, typically in a separate cycle.
Cramping after egg retrieval is common and usually settles within a day, and the fertility medicines can leave the abdomen bloated for a while. Follow the clinic's instructions about driving and activity after the pain medicines given for the retrieval. When the genetic results are ready, the genetic counselor or doctor reviews them, including any embryos that gave no clear answer. For a family's known single-gene condition, an embryo without a clear result is generally not chosen for transfer. If a pregnancy follows, prenatal testing is still offered to confirm the embryo result, because embryo testing can occasionally miss or misread a problem. Options range from screening, such as ultrasound and blood tests, to diagnostic tests such as chorionic villus sampling (CVS, which takes a small sample of the placenta) or amniocentesis (which samples the fluid around the baby). Some people choose to confirm the result with a test on cord blood at birth instead. After IVF, contact the fertility team right away for a fever over 100.5°F (38°C), pelvic pain beyond mild cramping, heavy vaginal bleeding or blood in the urine. Rapid weight gain, passing much less urine than usual, nausea and vomiting, or shortness of breath can be signs of ovarian hyperstimulation syndrome and also need a prompt call.
The physical risks come from IVF rather than from the genetic test. Fertility medicines can cause bloating, abdominal discomfort and mood changes, and in rare cases ovarian hyperstimulation syndrome, in which fluid builds up in the abdomen and sometimes the chest; severe cases can need the fluid drained or a hospital stay. Egg retrieval carries small risks of bleeding, infection, a reaction to anesthesia and injury to nearby organs such as the bowel or bladder. The main limitations concern the result itself. Most centers report overall misdiagnosis rates of roughly 1 to 3 percent, so a normal result is not a guarantee of a baby without genetic problems. PGT-M looks only for the family's known condition, and embryo testing can miss very small missing or extra pieces of chromosomes, brand-new gene changes and some other conditions. In PGT-A, some embryos show a mix of normal and abnormal cells, called mosaicism, which makes results harder to interpret. A cycle may also end with no embryo that is both unaffected and healthy enough to transfer, and more than one cycle may be needed. The chance of a live birth depends heavily on age and the reason for testing. A review of mostly observational studies found no extra pregnancy or newborn complications after PGT-A compared with IVF alone, while information on the other types is more limited. The process is costly, often only partly covered by insurance, and emotionally demanding, especially for families already caring for an affected child.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience with Preimplantation Diagnosis, what to expect, or ask the community a question.